Eloxx Pharmaceuticals Price Prediction

ELOXDelisted Stock  USD 6.12  0.30  4.67%   
The relative strength index (RSI) of Eloxx Pharmaceuticals' the pink sheet price is slightly above 66 suggesting that the pink sheet is rather overbought by investors at this time. The main point of the Relative Strength Index (RSI) is to track how fast people are buying or selling Eloxx, making its price go up or down.

Oversold Vs Overbought

66

 
Oversold
 
Overbought
The successful prediction of Eloxx Pharmaceuticals' future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Eloxx Pharmaceuticals, which may create opportunities for some arbitrage if properly timed.
Using Eloxx Pharmaceuticals hype-based prediction, you can estimate the value of Eloxx Pharmaceuticals from the perspective of Eloxx Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Eloxx Pharmaceuticals to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying Eloxx because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Eloxx Pharmaceuticals after-hype prediction price

    
  USD 6.12  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
Intrinsic
Valuation
LowRealHigh
5.675.676.73
Details
Naive
Forecast
LowNextHigh
4.614.614.61
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
5.886.467.04
Details

Eloxx Pharmaceuticals After-Hype Price Prediction Density Analysis

As far as predicting the price of Eloxx Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Eloxx Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Eloxx Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Eloxx Pharmaceuticals Estimiated After-Hype Price Volatility

In the context of predicting Eloxx Pharmaceuticals' pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Eloxx Pharmaceuticals' historical news coverage. Eloxx Pharmaceuticals' after-hype downside and upside margins for the prediction period are 6.12 and 6.12, respectively. We have considered Eloxx Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
6.12
6.12
After-hype Price
6.12
Upside
Eloxx Pharmaceuticals is very steady at this time. Analysis and calculation of next after-hype price of Eloxx Pharmaceuticals is based on 3 months time horizon.

Eloxx Pharmaceuticals Pink Sheet Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Eloxx Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Eloxx Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Eloxx Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
 0.00  
0.00
 0.00  
 0.00  
0 Events / Month
12 Events / Month
In a few days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
6.12
6.12
0.00 
0.00  
Notes

Eloxx Pharmaceuticals Hype Timeline

Eloxx Pharmaceuticals is currently traded for 6.12. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Eloxx is estimated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is estimated to be very small, whereas the daily expected return is currently at 0.0%. %. The volatility of related hype on Eloxx Pharmaceuticals is about 0.0%, with the expected price after the next announcement by competition of 6.12. About 37.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 12.93. Eloxx Pharmaceuticals last dividend was issued on the 20th of December 2017. The entity had 1:40 split on the 2nd of December 2022. Given the investment horizon of 90 days the next estimated press release will be in a few days.
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

Eloxx Pharmaceuticals Related Hype Analysis

Having access to credible news sources related to Eloxx Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Eloxx Pharmaceuticals' future price movements. Getting to know how Eloxx Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Eloxx Pharmaceuticals may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
ZURAZura Bio Limited(0.21)9 per month 0.00 (0.10) 7.95 (7.94) 26.70 
CYTOAltamira Therapeutics(0.01)7 per month 0.00 (0.24) 7.32 (10.87) 22.81 
IMMXImmix Biopharma(0.04)4 per month 4.54 (0.01) 9.38 (8.22) 32.68 
ENVBEnveric Biosciences 0.08 6 per month 0.00 (0.15) 6.25 (7.50) 28.33 
PALIPalisade Bio 0.03 6 per month 0.00 (0.12) 5.97 (8.55) 24.25 
SGTXSigilon Therapeutics(5.67)8 per month 6.43  0.11  12.46 (14.07) 442.39 
RVPHReviva Pharmaceuticals Holdings(0.04)5 per month 5.90  0.06  10.71 (9.86) 40.06 
ZVSAZyVersa Therapeutics(0.01)5 per month 0.00 (0.15) 7.57 (9.60) 78.93 
KRBPKiromic Biopharma(0.24)3 per month 0.00 (0.03) 12.04 (10.96) 65.24 
UNCYUnicycive Therapeutics(0.05)7 per month 4.13  0.20  10.26 (7.32) 29.22 
EFTREffector Therapeutics(0.06)4 per month 0.00 (0.31) 8.70 (27.78) 88.91 
ELEVElevation Oncology(0.02)9 per month 0.00 (0.05) 5.77 (8.22) 22.21 
CFRXContraFect Corp 0.01 1 per month 0.00 (0.04) 12.23 (8.45) 55.69 
ALLRAllarity Therapeutics 0.07 10 per month 0.00 (0.27) 10.85 (16.11) 41.48 
CNSPCns Pharmaceuticals(0.01)6 per month 0.00 (0.06) 9.09 (8.33) 39.29 
WINTWindtree Therapeutics(0.15)7 per month 0.00 (0.28) 12.00 (18.48) 60.67 

Eloxx Pharmaceuticals Additional Predictive Modules

Most predictive techniques to examine Eloxx price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Eloxx using various technical indicators. When you analyze Eloxx charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Eloxx Pharmaceuticals Predictive Indicators

The successful prediction of Eloxx Pharmaceuticals stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Eloxx Pharmaceuticals, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Eloxx Pharmaceuticals based on analysis of Eloxx Pharmaceuticals hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Eloxx Pharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Eloxx Pharmaceuticals's related companies.

Story Coverage note for Eloxx Pharmaceuticals

The number of cover stories for Eloxx Pharmaceuticals depends on current market conditions and Eloxx Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Eloxx Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Eloxx Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Eloxx Pharmaceuticals Short Properties

Eloxx Pharmaceuticals' future price predictability will typically decrease when Eloxx Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Eloxx Pharmaceuticals often depends not only on the future outlook of the potential Eloxx Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Eloxx Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding2.2 M
Cash And Short Term Investments19.2 M
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Other Consideration for investing in Eloxx Pink Sheet

If you are still planning to invest in Eloxx Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Eloxx Pharmaceuticals' history and understand the potential risks before investing.
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
FinTech Suite
Use AI to screen and filter profitable investment opportunities
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas